//
Cardiovascular Toxicity in Cancer Survivors: Current Guidelines and Future Directions
Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1
Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers
Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association
Lack of Association Between Heart Failure and Incident Cancer
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis
Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2